IRONWOOD PHARMACEUTICALS INC financial statements, including revenue, expenses, profit, and loss
The total revenue of I76 for the last quarter is 69.39 M EUR, and it's 34.84% lower compared to the previous quarter. The net income of Q1 24 is -3.86 M EUR.